The Study of Bendamustine, Rituximab, Ibrutinib, and Venetoclax in Relapsed, Refractory Mantle Cell Lymphoma

Trial of YUMI Uterine Manipulator

Short Course Daratumumab in Patients With Multiple Myeloma

A Study of Several Radiation Doses for Patients With Progression on Immunotherapy/Checkpoint Inhibitors

A Study of Colesevelam for Lenalidomide-Associated Diarrhea

Brentuximab Vedotin Combined With AVD Chemotherapy in Patients With Newly Diagnosed Early Stage, Unfavorable Risk Hodgkin Lymphoma

Selective Inhibitor of Nuclear Export, Selinexor (KPT-330) in Combination With Paclitaxel and Carboplatin in Patients With Advanced Ovarian or Endometrial Cancers

Major Radiation Reduction for HPV+ Oropharyngeal Carcinoma

Testing Lenvatinib and Cetuximab in Patients With Advanced Head and Neck Squamous Cell Carcinoma and Cutaneous Squamous Cell Carcinoma

A Study of Carfilzomib, Lenalidomide, Dexamethasone and Daratumumab for Patients With Relapsed/Refractory Myeloma With Salvage Autologous Hematopoietic Cell Transplantation

Evaluating Cancer Response to Treatment With Abemaciclib and Fulvestrant in Women With Recurrent Endometrial Cancer

Cabozantinib in Combination With Cetuximab in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Cancer

Study of Pembrolizumab in Patients With Early-Stage NK/T-cell Lymphoma, Nasal Type

Reflectance Confocal Microscopy of Oral Cancers in Vivo: a Preliminary Trial Comparing Intra-oral Imaging With Pathology

Evaluation of Treatment Response Using Multiparametric MRI After Prostate Radiotherapy

Proton Re-Irradiation for Recurrent Head and Neck Cancer

AZD5363 in Patients With Advanced Solid Tumors Harboring AKT Mutations

Pevonedistat Alone and in Combination With Chemotherapy in Patients With Mesothelioma

A Study to Test Radium-223 With Docetaxel in Patients With Prostate Cancer

Study of Zanubrutinib, Obinutuzumab, and Venetoclax in Patients With Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL)

Investigating the Effectiveness of Stereotactic Body Radiotherapy (SBRT) in Addition to Standard of Care Treatment for Cancer That Has Spread Beyond the Original Site of Disease

Quality of Life in Patients Undergoing Total Pelvic Exenteration

A Study of Durvalumab With or Without Tremelimumab in Endometrial Cancer

RAI Plus Immunotherapy for Recurrent/Metastatic Thyroid Cancers

Study of Nivolumab Plus Ipilimumab in Patients With Salivary Gland Cancer

Radiotherapy to the Prostate and Dominant Intra-Prostatic Lesion (DIL)

A Study of Rucaparib Administered With Radiation in Patients With Triple Negative Breast Cancer With an Incomplete Response Following Chemotherapy

Use of High-dose Radiation Therapy Plus Chemotherapy to Improve the Likelihood of Surgical Treatment in Patients With Locally Advanced Pancreatic Cancer

RO5126766 for Patients With Advanced KRAS-Mutant Lung Cancer

A Study of Dacomitinib in Patients With Metastatic EGFR Mutant Lung Cancer Previously Treated With Osimertinib

Randomized Study of Stereotactic Body Radiation Therapy (SBRT) in Patients With Oligoprogressive Metastatic Cancers of the Breast and Lung

Clinical Significance of Germline BRCA Mutations

Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders

Afatinib and Paclitaxel in Patients With Advanced HER2-Positive Trastuzumab-Refractory Advanced Esophagogastric Cancer

Prospective Registry of Multiplex Testing (PROMPT)

Immunotherapy and Stereotactic Body Radiotherapy (SBRT) for Metastatic Anaplastic Thyroid Cancer

A Clinical Trial of Endoscopic Surgery Followed by Chemotherapy and Proton Radiation for the Treatment of Tumors in the Sinus and Nasal Passages

Exercise, Fitness and Tumor Profiling in Breast Cancer Patients

Study of the PD-L1 Inhibitor Atezolizumab With or Without Low-dose, Local Radiation in Patients With Relapsed or Refractory Advanced Stage Follicular Lymphoma

A Study of Olaparib and Low Dose Radiotherapy for Small Cell Lung Cancer

Treating Patients With Melanoma and ALK Alterations With Ensartinib

A Study of Nivolumab In Combination With Cabozantinib in Patients With Non-Clear Cell Renal Cell Carcinoma

A Study of Flibanserin in Breast Cancer Survivors on Tamoxifen

Study of Pembrolizumab or Placebo Following Surgery in Patients With Microsatellite Instability High (MSI-H) Solid Tumors

DS-3201b and Irinotecan for Patients With Recurrent Small Cell Lung Cancer